chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pharmacist was in the process of administering my flu shot, while the needle was in my arm an employee opened the door behind him, knocking him forward sending the needle further into my arm than intended. Shocked that this happened, I question the pharmacist how a room designated for vaccines could be accessed with such negligence. He did not offer an explanation but did apologize and told me that the employee would be reprimanded. My arm still tingles and throbs periodically. My shoulder also hurts occasionally. My Dr checked my arm and doesn't see any visible issues, he did not prescribe any medications because I am pregnant. He asked me to do a few exercises to try to relieve the stiffness in my shoulder.
Patient states he had a round, orange sized, red, itchy rash around the injection site since the injection date. Rash was visibly not noticible on 1/24/18 but patient complained site still was itchy. He also stated he had feelings of weakness, fever, malaise since injection. He stated he had been applying calamine lotion on the itch as well as another unknown cream to help the itching.
Pt recv vax on 6/10/98; on 6/10/98 pt exp crying x 7 hr, fever (103); pt to E.R x several hr.;  tx=Tylenol
Blindness/stroke in left eye. Treatment-Hospital admission-no treatment able to be provided. Outcome: permanent blindness in left eye
This spontaneous report was received from a health professional (immunization official) and refers to an unspecified number of patients of  unknown age and sex. No pertinent medical history or concurrent conditions were reported. On an unknown date, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX through an unspecified route. No adverse effects were reported. The outcome of incorrect product storage was unknown. Additional information has been requested.
Patient states that the muscle soreness at the injection site still has not subsided after 3 and 1/2 weeks. I recommended OTC acetaminophen until he is able to see a doctor to assess.
Given by DOH, immediate itching/palpitations medics sent her for evaluation tachycardic, a few hives on right cheek, wheezing  no hypotension Given benadryl 25 mg IV, famotidine 20 mg IV with prompt resolution of sympotms Observed and discharged on oral anti histamines
Muscle pain; Joint pain; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Unknown, Expiry Date: Unknown) via an unspecified route of administration on Thursday an unspecified date in 2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced minor side effects of muscle pain, joint pain on an unspecified date in 2021. Patient was trying to find out is how long do the side effects continue after the first shot. The clinical outcome of all events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Systemic: Chills-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Vomiting-Severe, Additional Details: Patient had chills, passed out for 20 seconds and regained consciousness
FEVER, SLEEPLESSNESS, ACHING ALL OVER THE BODY AND JOINTS, LOSS OF APPETITE, 6 BOWEL MOVEMENTS ONE DAY LONG, SEVERE SWEATS AND COLD CHILLS, ACHING ARM, REDNESS AROUND INJECTION SITE, SWOLLEN, ITCHY, AND PAINFUL TO RAISE OR USE THE ARM.
This spontaneous report was received from a healthcare professional who reported that on unspecified dates, an unspecified number of doses of COMVAX (intramuscular injection, dose number, route, batch and lot #, expiration date not reported) could have been administered to an unspecified amount of patients. No adverse events reported. Further information was not provided. This is one of several reports from the same source. Additional information has been requested.
Had initial redness, swelling and pain at injection site. Resolved after 2-3 days, then mildly itchy.  One week later, swelling, pain, itching have recurred.  Day 8 with 5x8 cm red, tender, itchy swelling left deltoid at injection site.  Unexpected after reviewing published side effects.
12/23-developed rash and fever 12/25-admited to hospital for abnormal labs; enlarged liver.  Dx with kawasaki disease
Patient had a erythematous, papular rash on dermatome L3 of left leg that started 12/20 with mild burning pain and numbness sensation. Pt was treated for Shingles and started on Valacyclovir today 12/211/2022
Patient hospitalized for acute hypoxia related to COVID 19. Required dexamethasone, nebulizers, oxygen, and remdesivir treatment. Was discharged with home O2.
She starting not feeling well on 11/22/18 and by 11/25/18 came into the pharmacy where she had a large red circle raised area with itching. She then went to local clinic for further evaluation.
Diffuse rash, starting the day after vaccination. Itching only.  No swelling, difficulty breathing. Antihistamines prescribed.
This patient had the second MODERNA yesterday. When document, we saw that he had a full set of MODERNA at another facility. Called patient and he confirmed that he had 2 doses of MODERNA on 2/15/21 and 3/17/21. Patient then made appointment with a COVID center and had 2 doses of MODERNA 4/5/21 and 5/3/21. He said he needed double dosage because he is high risk.
STLL FEEL LIKE; EVERY JOINT IN MY BODY HURTS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination.The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced stll feel like, and every joint in my body hurts. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the every joint in my body hurts and stll feel like was not reported. This report was non-serious.
Pt recvd 3rd dose of Hep B on 20MAR92; approx 1-1/2 hrs post vax pt devel a patchy red rash, accompanied by pruritis @ inject site, across chest, shoulders & neck;@ time of report pt recovered;
Expired dose administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 40-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis.   On 12th July 2022, the patient received the 1st dose of Boostrix. On 12th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 19-Jul-2022 Reporter comment: Certified medical assistant reported that expired dose was administered to a male patient. The reporter consented to follow up. Additional Supportive Information:  The patient was administered an expired dose of Boostrix, which led to expired vaccine used.
I received the Johnson & Johnson COVID-19 vaccination at around 1:30pm. At about 8pm, 7 and a half hours after receiving the dose I spiked a fever of 102 with sever chills, uncontrolled shaking and a headache.  I took Excedrin for the headache and fever and went to bed early. The fever broke just after 1am in morning and I went back to sleep. I woke in the morning  of the 19th to my joints hurting, pain at the injection site that extends to my entire upper arm and another sever headache. Today is now the 22nd and I am continuing to have headaches. My joints no longer ache but my upper arm where I was injected is still extremely tender to the touch. I am continuing to take Excedrin to help deal with the pain.
Aches; Low grade fever of 100-101; Chills; Vomiting; Nausea; This is a spontaneous report received from a contactable consumer or other non hcp. A 15-years-old female patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 03Jun2021 09:00,at the age of 15 years old,as Dose 2,single for covid-19 immunization.The patient medical history was not reported.The patient experienced aches, low grade fever of 100-101 , chills, vomiting and nausea on 03Jun2021 16:00.The patient underwent lab tests and procedures which included body temperature: 100-101 on 04Jun2021.The patient was not diagnosed for covid prior vaccination and not tested for covid post vaccination.The patient reported no allergies.The patient received no treatment for the event.The outcome of the event was not recovered.  Follow-up (23Jul2021): This is a follow-up spontaneous report received from a contactable other HCP. This other HCP reported in response to HCP letter sent, in which included that patient reported adverse event with use of the Pfizer covid vaccine.  Information on the lot/batch number has been requested.
their first dose was 11Aug2021 and their second dose was 12Oct2021; Just a little pain; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A 14 year-old male patient received bnt162b2 (BNT162B2), administration date 12Oct2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: 11Aug2021, for COVID-19 Immunization, reaction(s): "Just a little pain". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "their first dose was 11Aug2021 and their second dose was 12Oct2021"; PAIN (non-serious) with onset 2021, outcome "unknown", described as "Just a little pain".  Additional Information: Caller had two male patients in his office on 21Feb2021 that asked for a booster [Pfizer BioNTech Covid-19 Vaccine]. 14 years old and 15 years old. They told him their last doses were given in the summer. Their mother was telling him they were given in Aug2021. He gave them the booster, 0.3mL, to both. The LOT number was FK9896. He made a mistake and did not ask for their vaccination cards until after, and he saw that their first dose was 11Aug2021 and their second dose was 12Oct2021. He was counting the interval between their last dose and the booster, and it was 19 days short of five months. They did very good with the first two doses. Just a little pain. So, he was hoping they do okay with the booster even though they got it early. Caller asking for any supporting documentation Pfizer may have to shed further light on her situation regarding efficacy and safety of a booster dose given earlier than 5 months after completing the primary series. Caller went on to say, he have one or two patients to whom he gave the first dose that didn't come to get their second dose for a month or two after the first dose, but he went ahead and gave the second dose. Some had diarrhoea and vomiting after eating something but it was not related to the vaccine. Two patients he had from before had a big interval before the second dose. Caller also asking, the booster dose is 0.3 (mL) Or is it 0.5 he thought it was 0.5mL for adults.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200317235 same reporter/different patient/same AE;US-PFIZER INC-202200323191 same reporter/different patient/same AE
had flu shot on Oct 19, became sick with flu on Oct 22, rather severe, sore throat, fever, headache, unable to eat for 24 hours.
Pt vaccinated with Pneumovax 23 developed multilobular pneumonia. Lab eval of sputum revealed type III strep pneumococcus. BY 2FEB90 pt symptoms were resolving, being treated w/Penicillin & a bronchodilator.
At clinic for first pfizer dose became pale and diaphoretic vaso vagel . Assisted to stretcher Legs elevated. Ice pack applied  Seen by Dr .  BP 102/60 Observed x 30 min then d/ c home with parents.
Erythema and urticaria of L Ant thigh at injection site - no cellulitis. Tx - XYZAL.
Tinnitus has become very loud.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Mar2021(at the age of 59-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 09Apr2021 as a single dose for COVID-19 immunisation. Medical history included blood pressure high and cholesterol high. Concomitant medications included lisinopril dihydrate (LISINOPRIL) and pravastatin (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 the patient experienced tinnitus that had become very loud. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tinnitus has become very loud was not recovered at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
arm was sore; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (arm was sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced MYALGIA (arm was sore). At the time of the report, MYALGIA (arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   No concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-322585 (Patient Link).
Pt did not respond to Engerix-B vax series; 9FEB92 HBSAB neg; 1 booster does has been given;
Pt reports long hx back problems / pain. Previously seeing chiropractor for back & neck pain. Symptoms had improved. Was seeing chiropractor 1x wk. After injection pain in arm up neck & into shoulder blade.
Information has been received from an office manager concerning an infant whose 21 year old mother with a history of pyloric stenosis, papanicolaou smear abnormal, ovarian cysts, prior loop electrosurgical excision procedure, pre-term delivery (35 weeks) with pre-eclampsia and pre-term premature rupture of membranes with her prior pregnancy who on 26-JUN-2008 and 29-SEP-2008 was vaccinated intramuscularly in the right deltoid with a first and second 0.5 ml doses, respectively, of GARDASIL (Lot # of the second dose: 0573X). There was no birth defect in previous pregnancy. There was no concomitant medication. Subsequently the patient became pregnant. The patient was seen at the practice. On 14-OCT-2008, the patient was 5-6 weeks gestation. Estimated date of delivery was approximately 09-JUN-2009. On 20-OCT-2008 an ultrasound revealed that the fetal heart rate was 124 bpm and the cervix was 3 cm. The office manager reported that they did not have any information on the infant, and she did not call the patient concerning this registry. There was a note written at postpartum visit that the infant was seeing a cardiologist for heart valve. Heart valve disease was considered to be congenital anomaly. The mother's experience is reported in WAES #0810USA02447. Additional information has been requested.
20APR93 pink patch in area of inject 3" wide 5" long, became hot w/swelling & mild itching; 21APR93 local rxn plus vomiting, dizziness, fainting; 22APR93 prostration;
I received the second Moderna shot on 9/10/21 and have yet to get my period. My period usually starts on the 3rd day of each month.  It?s now 10/13/21. It?s 11 days late. Took 4 pregnancy tests and all were negative. No spotting. No major PMS symptoms to report. Hoping it comes back.
Guillen Barre Syndrome; bedfast; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant) and bedridden. On an unknown date, the outcome of the guillain barre syndrome and bedridden were unknown.   It was unknown if the reporter considered the guillain barre syndrome and bedridden to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient's wife. The reporter stated that the patient had been bedfast with Guillen barre syndrome for 3 years. The reporter also asked that could we refer her to someone who might know if this was caused by the shingles vaccine. The follow-up would not possible as no contact details were available.
Patient presented to the emergency room 01/24/2014. Pt c/o pain and swelling, at the site, from a vaccination received yesterday here. Right shoulder with localized edema, no redness. Pt also stated he felt chills last night. Pt denies SOB, wheezing. Shoulder pain intense with movement. Minimal pain at rest.  Methylprednisolone 300 mg UD, acetaminophen/hydrocodone 1 to 2 tablets mg PRN, clindamycin mg QID.
Dizziness, shakes, blurred vision, heart palpitations, high blood pressure, fatigue, nausea, headaches
Red, tender rash just above buttocks. Also spreading to inner thigh. Patient states no complaints of pain. Treatment given of Valtrex 500mg 3 times a day for 7 days.  The report we just received following a patient's adverse event to a vaccine is parly incorrect.  Our patient received ZOSTAVAX "shingles" vaccine on 10/31/06 and reported an adverse event 11/18/06.  She developed shingles about 2 1/2 weeks after receiving the ZOSTAVAX vaccine.  This was confirmed by her internist physician on 11/28/06.  The only other vaccine the patient received with ZOSTAVAX was Influenza vaccine, each vaccine was given in separate deltoid.  There was no complaint of an adverse event following the Influenza vaccine by the patient.  In conclusion the patient had an adverse advent following administration of ZOSTAVAX "shingles" vaccine.  She was treated and has recovered since.  Please see below for information on the ZOSTAVAX vaccine given to patient on 10/31/06:
Based on additional information received on 11-Aug-2016, new company suspect drug influenza vaccine was added. Initial information regarding this clinical sponsored solicited case was received on 03-Dec-2015 from a consumer (patient's daughter) via the Patient Support Program. This case concerns a female patient of an unknown age who developed kidney infection, bladder infection, staph infection, flu-like symptoms, UTI, felt weak, washed out unspecified time duration after receiving Praluent and influenza vaccine. No past drugs, medical history or concurrent conditions were reported. On 27-Oct-2015, the patient received subcutaneous alirocumab at a dose of 75 mg every two weeks via alirocumab prefilled pen (concomitant device) (strength: 75 mg/ml; form, lot/batch number and expiry date: unknown) for hyperlipidemia nec/noc and cholesterol. On the same day the patient received influenza vaccine (Lot/ batch number, expiry date and other therapy details: unknown). The patient's daughter reported that patient received a sample medication from the medical doctor's office and patient experienced flu-like symptoms (onset and latency: unknown) and had kidney, bladder and staph infection (onset and latency: unknown for all events) while on the medication. On follow up it was reported that on an unknown date an unknown duration after receiving therapies, the patient felt weak and washed out, had UTI Action taken: no action was taken in response to the event (Therapy with alirocumab remained ongoing as planned). Corrective treatment: Not reported. Outcome: recovered for UTI, felt weak, washed out and unknown for rest all events. Reporter causality: Unknown for all events w.r.t alirocumab and not reported for influenza vaccine. Company causality: Not associated. Seriousness criteria: important medical event (kidney infection, bladder infection, staph infection and UTI). Additional information was received on 11-Aug-2016 from patient via patient support program: New company suspect drug influenza vaccine was added, height and weight were added, therapy details updated, new events of urinary tract infection, feelings of weakness and washed-out were added and text amended accordingly; Sender's Comments: Sanofi company comment dated 11-08-2016: This case concerns an 84-years old female patient who experienced kidney infection, bladder infection, urinary tract infection and staphylococcal infection after taking Alircoumab. The causal role of the drug with the event cannot be assessed due to lack of adequate information about patient's past medical history, concurrent conditions and concomitant medications. However, patient's advancing and female gender are the confounders for the same.
The first adverse event was aching of my joints in shoulders, elbows, and wrist on both sides of my body. I also developed numbness, tingling in my lower left arm, and hand. I went to my doctor, was referred to Orthopedic and Rheumatologist but neither identified the diagnosis, referred me to Physical therapy. Then recently I have developed PVC's and my doctor has referred me to the Cardiologist and Neurologist. I have been experiencing Ryanoids in my left hand more than right hand.
No reaction.  Patient was given first dose of Moderna at an alternate provider on 3/18/2021.
ACUTE PULMONARY EMBOLISM 10/16/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE  ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/16/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/16/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE
The pt contracted Guillain Barré syndrome and was treated for three weeks at the hospital. Has been in full rehab facilities since that time. Pt is  not able to walk or sit up. On the annual report received on 04/22/2003, the reporter states, "Patient is still unable to walk unassisted (uses walker). Needs assistance to dress, undress, toilet and food prep. Is homebound (90%). Has spent all savings on aides and can no longer afford them. Severe arthritis in right arm, hand, knee and ankle. Suffered hair loss due to stress."
noc following vax pt noticed a redness & tightness around arm from elbow up 6"-hot to touch-not @ inj site;
sudden jerk to one side of body, head pulled towards shoulder -shoulder towards ear w/a stiffening of entire body - & sometimes arm extends to a stiff up above head position usually occurs in 3's  then exhausted & sleeps.  Still occurring.